Vincerx Pharma board aproves 1-for-20 reverse stock split

Vincerx Pharma (VINC) announced that its board of directors approved a 1-for-20 reverse stock split of its issued shares of common stock, which will be effective as of January 27. Vincerx’s common stock will continue trading on The Nasdaq Stock Market under the existing symbol VINC and will begin trading on a split-adjusted basis when the market opens on January 28, 2025 with a new CUSIP number. The reverse stock split was approved by Vincerx’s stockholders at a special meeting of stockholders held on January 16 .